Outset Medical, Inc. (OM): Capital Expenditures
$798.0K
Year ended 2025-12-31
$559.0K
Trailing 12 months to 2026-06-30
-54.2%
3-year compound annual growth
-38.5%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $798.0K | -12.5% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $912.0K | -73.5% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $3.44M | -58.7% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $8.32M | +167.9% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $3.11M | -65.8% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $9.08M | +175.6% | 2023-02-13, From 2020-01-01 |
| 2019-12-31 | $3.29M | +86.5% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $1.77M | n/a | 2021-03-22, From 2018-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Outset Medical, Inc. (OM) | 2025-12-31 | $798.0K | -12.5% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $9.48M | +193.7% |
| Ceribell, Inc. (CBLL) | 2025-12-31 | $767.0K | -42.8% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $1.25M | +377.9% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $3.75M | +20.8% |
| Iridex Corp (IRIX) | 2026-01-03 | $143.0K | +1000.0% |
| InMode Ltd. (INMD) | 2025-12-31 | $972.0K | +45.3% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $93.0K | +173.5% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $66.0K | n/a |
Compare OM, BLFS, CBLL, ELMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗